Monday, July 12, 2010
Dr. Randy Schekman, editor-in-chief of the Proceedings of the National Academy of Sciences (PNAS), where the FDA/NIH XMRV ME/CFS paper had been accepted, gave CFS Central an update. The NIH's Dr. Harvey Alter, one of the authors of the study, told Schekman that he'll be returning the paper to the journal "within weeks." After that, the PNAS editorial board will consider the paper, which, Schekman says, is "standard procedure." The FDA/NIH study found the retrovirus XMRV in the majority of ME/CFS patients that it tested.
Posted Monday, July 12, 2010